A Conformational Restriction Strategy for the Control of CRISPR/Cas Gene Editing with Photoactivatable Guide RNAs

© 2022 Wiley-VCH GmbH..

The CRISPR/Cas system is one of the most powerful tools for gene editing. However, approaches for precise control of genome editing and regulatory events are still desirable. Here, we report the spatiotemporal and efficient control of CRISPR/Cas9- and Cas12a-mediated editing with conformationally restricted guide RNAs (gRNAs). This approach relied on only two or three pre-installed photo-labile substituents followed by an intramolecular cyclization, representing a robust synthetic method in comparison to the heavily modified linear gRNAs that often require extensive screening and time-consuming optimization. This tactic could direct the precise cleavage of the genes encoding green fluorescent protein (GFP) and the vascular endothelial growth factor A (VEGFA) protein within a predefined cutting region without notable editing leakage in live cells. We also achieved light-mediated myostatin (MSTN) gene editing in embryos, wherein a new bow-knot-type gRNA was constructed with excellent OFF/ON switch efficiency. Overall, our work provides a significant new strategy in CRISPR/Cas editing with modified circular gRNAs to precisely manipulate where and when genes are edited.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:62

Enthalten in:

Angewandte Chemie (International ed. in English) - 62(2023), 5 vom: 26. Jan., Seite e202212413

Sprache:

Englisch

Beteiligte Personen:

Sun, Ying-Jie [VerfasserIn]
Chen, Wen-Da [VerfasserIn]
Liu, Ji [VerfasserIn]
Li, Jun-Jin [VerfasserIn]
Zhang, Yu [VerfasserIn]
Cai, Wei-Qi [VerfasserIn]
Liu, Li [VerfasserIn]
Tang, Xin-Jing [VerfasserIn]
Hou, Jian [VerfasserIn]
Wang, Ming [VerfasserIn]
Cheng, Liang [VerfasserIn]

Links:

Volltext

Themen:

CRISPR/Cas
Circular gRNA
Gene Editing
Journal Article
Photo-Modulation
RNA, Guide, CRISPR-Cas Systems
Research Support, Non-U.S. Gov't
Spatiotemporal Control
Vascular Endothelial Growth Factor A

Anmerkungen:

Date Completed 23.01.2023

Date Revised 27.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/anie.202212413

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM349666350